<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>In a group of 993 patients with serious medical diseases an important deficiency of antithrombin III was found in patients with hepatic insufficiency, <z:hpo ids='HP_0002204'>pulmonary embolism</z:hpo> and with <z:hpo ids='HP_0005521'>disseminated intravascular coagulation</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>Acquired <z:hpo ids='HP_0001976'>antithrombin III deficiency</z:hpo> in these conditions develops when the antithrombin production in the liver is low and also in patients with shock syndrome and <z:hpo ids='HP_0005521'>disseminated intravascular coagulation</z:hpo> </plain></SENT>
<SENT sid="2" pm="."><plain>Assessment of antithrombin III is of diagnostic and prognostic value in thrombotic and prethrombotic conditions and its results is decisive for adequate substitution </plain></SENT>
<SENT sid="3" pm="."><plain>Adequate AT III substitution without concurrent <z:chebi fb="5" ids="28304">heparin</z:chebi> administration in patients with <z:e sem="disease" ids="C0036690" disease_type="Disease or Syndrome" abbrv="">septicaemia</z:e> and manifestations of <z:chebi fb="0" ids="53092">DIC</z:chebi> improves the prognosis of patients with an increased endothelial resistance </plain></SENT>
</text></document>